Mark L. Berch

Array ( [id] => 7226631 [patent_doc_number] => 20050261492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Regioselective hydroxylation, functionalisation and protection of spirolactams' [patent_app_type] => utility [patent_app_number] => 10/853639 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9099 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261492.pdf [firstpage_image] =>[orig_patent_app_number] => 10853639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931177 [patent_doc_number] => 06979681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/848416 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6355 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979681.pdf [firstpage_image] =>[orig_patent_app_number] => 10848416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582003 [patent_doc_number] => 07452991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Aztreonam β polymorph with very low residual solvent content' [patent_app_type] => utility [patent_app_number] => 10/847123 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1794 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452991.pdf [firstpage_image] =>[orig_patent_app_number] => 10847123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046164 [patent_doc_number] => 20050250759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Spirolactams and their synthesis' [patent_app_type] => utility [patent_app_number] => 10/846466 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6281 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250759.pdf [firstpage_image] =>[orig_patent_app_number] => 10846466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265062 [patent_doc_number] => 20040242598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Phosphodiesterase 4 inhibitors' [patent_app_type] => new [patent_app_number] => 10/845354 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17541 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242598.pdf [firstpage_image] =>[orig_patent_app_number] => 10845354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543378 [patent_doc_number] => 07169789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Quinoline derivatives and quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/842009 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 66195 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169789.pdf [firstpage_image] =>[orig_patent_app_number] => 10842009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786716 [patent_doc_number] => 20060205745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Microcrystal' [patent_app_type] => utility [patent_app_number] => 10/554511 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4848 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205745.pdf [firstpage_image] =>[orig_patent_app_number] => 10554511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 716026 [patent_doc_number] => 07053096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Compounds having selective hydrolytic potentials' [patent_app_type] => utility [patent_app_number] => 10/838296 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9385 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053096.pdf [firstpage_image] =>[orig_patent_app_number] => 10838296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7123114 [patent_doc_number] => 20050014943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Methods of synthesis for 9-substituted hypoxanthine derivatives' [patent_app_type] => utility [patent_app_number] => 10/838986 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6652 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014943.pdf [firstpage_image] =>[orig_patent_app_number] => 10838986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070353 [patent_doc_number] => 20050245738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/838431 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12352 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245738.pdf [firstpage_image] =>[orig_patent_app_number] => 10838431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7457753 [patent_doc_number] => 20040197396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Anhydrous crystal form of valaciclovir hydrochloride' [patent_app_type] => new [patent_app_number] => 10/494115 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10496 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197396.pdf [firstpage_image] =>[orig_patent_app_number] => 10494115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7435458 [patent_doc_number] => 20040266795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Process for the preparation of famciclovir' [patent_app_type] => new [patent_app_number] => 10/836028 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4448 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266795.pdf [firstpage_image] =>[orig_patent_app_number] => 10836028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463791 [patent_doc_number] => 07238700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/837290 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17108 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238700.pdf [firstpage_image] =>[orig_patent_app_number] => 10837290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061732 [patent_doc_number] => 20050004094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Cephem compounds' [patent_app_type] => utility [patent_app_number] => 10/833088 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9385 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004094.pdf [firstpage_image] =>[orig_patent_app_number] => 10833088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 654828 [patent_doc_number] => 07109190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => 'Carbacephem β-lactam antibiotics' [patent_app_type] => utility [patent_app_number] => 10/833599 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8464 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109190.pdf [firstpage_image] =>[orig_patent_app_number] => 10833599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061730 [patent_doc_number] => 20050004092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Penem derivatives and antimicrobial agent containing the same' [patent_app_type] => utility [patent_app_number] => 10/831694 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78456 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004092.pdf [firstpage_image] =>[orig_patent_app_number] => 10831694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7128077 [patent_doc_number] => 20050059821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Method for manufacture of ceftriaxone sodium' [patent_app_type] => utility [patent_app_number] => 10/830806 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15162 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059821.pdf [firstpage_image] =>[orig_patent_app_number] => 10830806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567931 [patent_doc_number] => 07847093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Processes for the preparations of cefepime' [patent_app_type] => utility [patent_app_number] => 10/552858 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5515 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/847/07847093.pdf [firstpage_image] =>[orig_patent_app_number] => 10552858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145591 [patent_doc_number] => 20050119244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Process for preparing cephalosporins with salified intermediate' [patent_app_type] => utility [patent_app_number] => 10/821986 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5913 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119244.pdf [firstpage_image] =>[orig_patent_app_number] => 10821986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494734 [patent_doc_number] => 07211668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'PNA monomer and precursor' [patent_app_type] => utility [patent_app_number] => 10/819769 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 20098 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211668.pdf [firstpage_image] =>[orig_patent_app_number] => 10819769 [rel_patent_id] =>[rel_patent_doc_number] =>)